Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3667703 | 0.82 | ALDH1A1 (0.38) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL28293733 | 0.70 | ALDH1A1 (0.43) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL3934067 | 0.70 | ALDH1A1 (0.43) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL969221 | 0.70 | ALDH1A1 (0.43) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL4405423 | 0.70 | ALDH1A1 (0.48) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL7295983 | 0.70 | — | — | |
| SCHEMBL6109960 | 0.70 | ALDH1A1 (0.36) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL23857807 | 0.69 | — | — | |
| SCHEMBL1416123 | 0.69 | — | — | |
| SCHEMBL966999 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1727526-A2 | PIPERAZINE UREA DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS | Schering Aktiengesellschaft (DE) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005079769-A2 | PIPERAZINE DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |